Cargando…
Protein neddylation as a therapeutic target in pulmonary and extrapulmonary small cell carcinomas
Small cell lung carcinoma (SCLC) is among the most lethal of all solid tumor malignancies. In an effort to identify novel therapeutic approaches for this recalcitrant cancer type, we applied genome-scale CRISPR/Cas9 inactivation screens to cell lines that we derived from a murine model of SCLC. SCLC...
Autores principales: | Norton, Justin P., Augert, Arnaud, Eastwood, Emily, Basom, Ryan, Rudin, Charles M., MacPherson, David |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Cold Spring Harbor Laboratory Press
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8168556/ https://www.ncbi.nlm.nih.gov/pubmed/34016692 http://dx.doi.org/10.1101/gad.348316.121 |
Ejemplares similares
-
High prevalence of TB disease in contacts of adults with extrapulmonary TB
por: Wingfield, Tom, et al.
Publicado: (2018) -
MYCN drives chemoresistance in small cell lung cancer while USP7 inhibition can restore chemosensitivity
por: Grunblatt, Eli, et al.
Publicado: (2020) -
Clinical Overview of Extrapulmonary Small Cell Carcinoma
por: Kim, Kyeong-Ok, et al.
Publicado: (2006) -
Merkel cell polyomavirus and extrapulmonary small cell carcinoma
por: HOURDEQUIN, KATHRYN C., et al.
Publicado: (2013) -
Overactivated neddylation pathway in human hepatocellular carcinoma
por: Yu, Jian, et al.
Publicado: (2018)